[144] C3.ai, Inc. SEC Filing
Rhea-AI Filing Summary
C3.ai, Inc. Form 144 filing (ticker: AI) reports a proposed sale of 46,881 common shares through Merrill Lynch on the NYSE with an aggregate market value of $796,292.03. The filing lists 134,349,704 shares outstanding for the issuer and an approximate sale date of 09/16/2025. The securities to be sold were recorded as acquired on 09/15/2025 through a restricted stock unit vest event totaling 89,007 shares, with payment noted on 09/16/2025. The filing also discloses prior sales by the same person: 17,689 common shares sold on 06/27/2025 with gross proceeds of $441,558.46. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.
Positive
- Transparent disclosure of the proposed sale under Rule 144 including broker, share count, and market value
- Records prior sale (17,689 shares on 06/27/2025 for $441,558.46), improving transaction traceability
- Includes attestation that the seller does not possess undisclosed material adverse information
Negative
- Insider selling of vested restricted stock units: proposed sale of 46,881 shares valued at $796,292.03
- Filing lacks any disclosure of a trading plan adoption date or additional context for the timing of the sale
Insights
TL;DR: Insider plans to sell vested RSUs totaling 46,881 shares (~$0.8M) via Merrill Lynch; prior sale of 17,689 shares was disclosed.
The filing is a routine Rule 144 notice showing disposition of shares that vested as restricted stock units on 09/15/2025 with an intended sale on 09/16/2025. The transaction uses a major broker and is recorded against the issuer's publicly reported share count. Disclosure of a prior sale on 06/27/2025 improves transparency. From a market-impact perspective, the sizes disclosed are small relative to the total shares outstanding noted in the filing; therefore the filing appears to be procedural compliance rather than an indicator of a company-level event.
TL;DR: The notice documents insider selling of vested RSUs and includes the required legal attestation; no undisclosed material facts asserted.
The form contains the required attestation that the seller lacks undisclosed material adverse information and references potential Rule 10b5-1 plan mechanics in the remarks. The record of both the vesting date and the broker facilitates investor scrutiny. The filing does not provide details on any trading plan adoption date or additional governance context, so it remains a compliance disclosure without broader governance implications stated in the document.